CytomX Therapeutics, Inc. (CTMX) by event type
CTMX moves most on analyst upgrades — a median of -2.68% at 30 minutes across 29 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the CTMX overview →
How CTMX reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,707 of 2,717 | 29 | -2.68% | 17% | -6.77% |
| Coverage initiations 1,702 of 2,283 | 16 | -0.23% | 31% | -0.52% |
| Rating reiterations 3,473 of 3,522 | 52 | -1.18% | 35% | -3.07% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how CTMX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · CTMX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CONMED Corporation (CNMD) | 268 | -0.11% | 47% |
| Codexis, Inc. (CDXS) | 267 | 0.00% | 51% |
| Galapagos NV - American Depositary Shares (GLPG) | 267 | -0.05% | 44% |
| Eyenovia, Inc. (EYEN) | 266 | -0.95% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.